Peripheral Ulcerative Keratitis Secondary to the Inactive COVID-19 Vaccine-CoronaVac

References

• Fedeli U, Schievano E, Avossa F, et al. Different approaches to the analysis of causes of death during the COVID-19 epidemic. Eur Rev Med Pharmacol Sci. 2021;25(9):3610–3613. doi:10.26355/eurrev_202105_25844.
   PubMed Web of Science ®Google Scholar
• Ng XL, Betzler BK, Testi I, et al. Ocular adverse events after COVID-19 vaccination. Ocul Immunol Inflamm. 2021:1–9. doi:10.1080/09273948.2020.1849735.
   PubMedGoogle Scholar
• Yagci A. Update on peripheral ulcerative keratitis. Clin Ophthalmol. 2012;6:747–754. Epub 2012/06/02. doi:10.2147/OPTH.S24947.
   PubMedGoogle Scholar
• Cao Y, Zhang W, Wu J, et al. Peripheral ulcerative keratitis associated with autoimmune disease: pathogenesis and treatment. J Ophthalmol. 2017;2017:7298026. doi:10.1155/2017/7298026.
   PubMed Web of Science ®Google Scholar
• Eiferman RA, Carothers DJ, Yankeelov JA Jr. Peripheral rheumatoid ulceration and evidence for conjunctival collagenase production. Am J Ophthalmol. 1979;87(5):703–709. Epub 1979/05/01. doi:10.1016/0002-9394(79)90308-8.
   PubMed Web of Science ®Google Scholar
• Clewes AR, Dawson JK, Kaye S, et al. Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristics. Ann Rheum Dis. 2005;64(6):961. doi:10.1136/ard.2004.023283.
   PubMed Web of Science ®Google Scholar
• Jevnikar K, Jaki Mekjavic P, Vidovic Valentincic N, Petrovski, G, Globocnik Petrovic, M. An update on COVID-19 Related Ophthalmic Manifestations. Ocul Immunol Inflamm, :2021 May 19;29(4): 684–689. doi: 10.1080/09273948.2021.1896008. Epub 2021Apr 7. PMID: 33826465.
   PubMed Web of Science ®Google Scholar
• Yuan P, Ai P, Liu Y, et al. Safety, tolerability, and immunogenicity of COVID-19 vaccines: a systematic review and meta-analysis. medRxiv. 2020 Nov 3;2020:20224998.
   Google Scholar
• Koong LR, Chee WK, Toh ZH, Ng XL, Agrawal R, Ho SL. Vogt-Koyanagi-Harada disease associated with COVID-19 mRNA vaccine. Ocul Immunol Inflamm. 2021 Aug 18 29(6):1212–1215. doi:10.1080/09273948.2021.1974492. Epub 2021 Sep 10. PMID: 34505819
   PubMed Web of Science ®Google Scholar
• David JA,Fivgas GD. Acute macular neuroretinopathy associated with COVID-19 infection. Ophthalmol Case Rep. 2021;24:101232. doi:10.1016/j.ajoc.2021.101232.
   PubMedGoogle Scholar
• Papasavvas I, Herbort CP Jr. Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. J Ophthalmic Inflamm Infect. 2021;11(1):21. Epub 2021/07/06. doi:10.1186/s12348-021-00251-5.
   PubMed Web of Science ®Google Scholar
• Fowler N, Mendez Martinez NR, Pallares BV, et al. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. Am J Ophthalmol Case Rep. 2021;23:101136. doi:10.1016/j.ajoc.2021.101136.
   PubMedGoogle Scholar
• Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following Vaccination for COVID-19. Ocul Immunol Inflamm .2021 May 19;29(4):741–742. doi:10.1080/09273948.2021.1949478. Epub 2021 Jul 2. PMID: 34213988.
   PubMed Web of Science ®Google Scholar
• Maleki A, Look-Why S, Manhapra A, et al. COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects: real or coincidence? J Ophthalmic Vis Res. 2021;16(3):490–501. doi:10.18502/jovr.v16i3.9443.
   PubMed Web of Science ®Google Scholar
• Pichi F, Aljneibi S, Neri P, et al. Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi. JAMA Ophthalmol. 2021;139(10):1131. doi:10.1001/jamaophthalmol.2021.3477.
   PubMed Web of Science ®Google Scholar
• ElSheikh RH, Haseeb A, Eleiwa TK, Elhusseiny AM. Acute uveitis following COVID-19 vaccination. Ocul Immunol Inflamm. 2021 Aug 18; 29(6):1207–1209. doi:10.1080/09273948.2021.1962917. Epub 2021 Aug 11. PMID: 34379565.
   PubMed Web of Science ®Google Scholar
• Wasser LM, Roditi E, Zadok D, et al. Keratoplasty rejection after the BNT162b2 messenger RNA vaccine. Cornea. Epub 2021/05/25. 2021;40(8):1070–1072. doi:10.1097/ICO.0000000000002761.
   PubMed Web of Science ®Google Scholar
• Rallis KI, Ting DSJ, Said DG, et al. Corneal graft rejection following COVID-19 vaccine. Eye. 2021. doi:10.1038/s41433-021-01671-2.
   PubMedGoogle Scholar
• Phylactou M, Li J-PO, Larkin DFP. Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine. British J Ophthalmol. 2021;105:893–896.
   PubMed Web of Science ®Google Scholar
• Crnej A, Khoueir Z, Cherfan G, et al. Acute corneal endothelial graft rejection following COVID-19 vaccination. J Fr Ophtalmol. 2021;44(8):e445–e7. doi:10.1016/j.jfo.2021.06.001.
   PubMed Web of Science ®Google Scholar
• Cheng JY, Margo CE. Ocular adverse events following vaccination: overview and update. Surv Ophthalmol. 2021; Epub 2021/04/19. doi:10.1016/j.survophthal.2021.04.001.
   PubMed Web of Science ®Google Scholar
• Benage M, Fraunfelder RW. Vaccine associated uveitis. Invest Ophthalmol Vis Sci. 2015;56:5789.
   Web of Science ®Google Scholar
• Cunningham ET, Moorthy RS, Fraunfelder FW, et al. Vaccine-associated uveitis. Ocul Immunol Inflamm. 2019;27(4):517–520. doi:10.1080/09273948.2019.1626188.
   PubMed Web of Science ®Google Scholar
• Wen J, Cheng Y, Ling R, et al. Antibody-dependent enhancement of coronavirus. Int J Infect Dis. 2020;100:483–489. doi:10.1016/j.ijid.2020.09.015.
   PubMed Web of Science ®Google Scholar
• Gao Q, Bao L, Mao H, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. Epub 2020/05/08. 2020;369(6499):77–81. doi:10.1126/science.abc1932.
   PubMed Web of Science ®Google Scholar
• Huerva V, Ascaso FJ, Grzybowski A. Infliximab for peripheral ulcerative keratitis treatment. Medicine (Baltimore). 2014;93(26):e176. doi:10.1097/MD.0000000000000176.
   PubMed Web of Science ®Google Scholar
• Artifoni M, Rothschild P-R, Brézin A, et al. Ocular inflammatory diseases associated with rheumatoid arthritis. Nat Rev Rheumatol. Epub 2013/12/11. 2014;10(2):108–116. doi:10.1038/nrrheum.2013.185.
   PubMed Web of Science ®Google Scholar
• McGhee CN, Patel DV. Mooren’s ulcer and amniotic membrane transplant: a simple surgical solution? Clin Exp Ophthalmol. 2011;39(5):383–385. Epub 2011/07/14. doi:10.1111/j.1442-9071.2011.02605.x.
   PubMed Web of Science ®Google Scholar
• Zheng X, de Paiva CS, Li D-Q, et al. Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway. Invest Ophthalmol Vis Sci. 2010;51(6):3083–3091. doi:10.1167/iovs.09-3838.
   PubMed Web of Science ®Google Scholar